Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pegylated interleukin 2 - CS Bay Therapeutics

Next Previous
Drug Profile

Pegylated interleukin 2 - CS Bay Therapeutics

Alternative Names: PEGylated IL-2

Latest Information Update: 23 Jun 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CS-Bay Therapeutics
  • Class Antineoplastics; Interleukins
  • Mechanism of Action Interleukin 2 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 01 Jun 2022 CS Bay Therapeutics announces intention to submit an IND application with the regulatory bodies for cancer in the first quarter of 2023 (CS Bay Therapeutics pipeline, June 2022)
  • 08 Apr 2022 Pharmacodynamics data from a preclinical trial in non-small cell lung cancer presented at the 113th Annual Meeting of the American Association for Cancer Research (AACR-2022)
  • 01 Jan 2022 Preclinical trials in Cancer in USA and China (Parenteral)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top